Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Baber Research Group
mi
from
Naperville, IL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pedia Research, LLC
mi
from
Newburgh, IN
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pedia Research, LLC
mi
from
Newburgh, IN
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Psychiatric Associates
mi
from
Overland Park, KA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pedia Research LLC
mi
from
Owensboro, KY
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pedia Research LLC
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfied Hills, MI
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfied Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Midwest Research Group
mi
from
St. Charles, MO
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Duke University Medical Center, Duke Child and Family Study Center
mi
from
Durham, NC
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Duke University Medical Center, Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
IPS Research Company
mi
from
Oklahoma City, OK
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Cyn3rgy Research
mi
from
Gresham, OR
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
BioBehavioral Research of Austin
mi
from
Austin, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Bayou City Research Corporation
mi
from
Houston, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Bayou City Research Corporation
mi
from
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Houston Clinical Trials, LLC
mi
from
Houston, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Houston Clinical Trials, LLC
mi
from
Houston, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Road Runner Research
mi
from
San Antonio, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Family Psychiatry of the Woodlands
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Hugo W. Moser Research Institute at Kennedy Krieger Inc.
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Massachusetts General Hospital
mi
from
Boston, MA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated:  12/1/2016
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated: 12/1/2016
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated:  12/1/2016
Orlando Clinical Research Center
mi
from
Orlando, FL
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated: 12/1/2016
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated:  12/1/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated: 12/1/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated:  12/1/2016
DaVita Clinical Research
mi
from
Minneapolis, MN
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated: 12/1/2016
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated:  12/1/2016
American Research Cororation (ARC), Texas Liver Instituete (TLI)
mi
from
San Antonio, TX
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction
Status: Enrolling
Updated: 12/1/2016
American Research Cororation (ARC), Texas Liver Instituete (TLI)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Anniston, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Birmingham, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Northport, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Northport, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Mesa, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Sun City, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Tucson, AZ
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Little Rock, AR
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Sepuldeva, CA
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Sepuldeva, CA
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Washington,
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Washington,
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Hollywood, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated:  12/2/2016
GSK Investigational Site
mi
from
Maitland, FL
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects With Partial Seizures
Status: Enrolling
Updated: 12/2/2016
GSK Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials